Info@ThinkPinkRocks.org

Comorbid conditions that could affect the choice of tyrosine kinase inhibitor are common in patients with chronic myeloid leukaemia, finds an analysis of a US claims database.

Read the original post:
Comorbidities relevant to CML TKI choice common

Scroll to Top